How can policy makers and health care leaders ensure affordable, equitable access to GLP-1 medications while managing their ...

Amgen today announced financial results for the first quarter of 2025. "Demand for our products was strong globally in the first quarter. Ongoing new product launches and successful Phase 3 trial ...

Construction workers have a higher risk for developing cardiovascular disease. In fact, 1 in 25 workers has already been diagnosed with cardiovascular disease. That's why Big-D Companies is the ...

CSK remained bottom of the points table while SRH jumped a place to rise to the eighth spot. This was SRH's first win at the Chepauk against CSK. Here's how the IPL 2025 points table looks like ...

− Recommended Approval Based on the Pivotal HELIOS-B Phase 3 Study in which Vutrisiran Demonstrated Significant Reductions in Mortality and Cardiovascular ... New England Journal of Medicine.1 ...

The term "Raynaud's disease" is too often indiscriminately applied to such cases. Raynaud 1 did describe a clinical entity. The disease properly known by his name is characterized by digital ...

If you clench your hand into a fist, this is approximately the same size as your heart. It is located in the middle of the chest and slightly towards the left. The heart is a large muscular pump ...

As earlier outlined, short-term studies in animals and humans have shown GLP-1 to have some direct vasorelaxation ... which are summarized in Table 3.